News | April 20, 2026
Lupin subsidiary settles US antitrust case with Humana for $30 Million
The litigation involved multiple civil lawsuits alleging anti-competitive practices and violations of federal
The litigation involved multiple civil lawsuits alleging anti-competitive practices and violations of federal
TFOS is indicated for the treatment of pulmonary arterial hypertension
The supplemental adolescent approval enhances Solosec’s strong position as the first and only single-dose oral prescription antimicrobial agent approved for the treatment of both trichomoniasis and BV
SOLOSEC is designed to be easy to take and one oral dose contains a complete course of treatment
The board has approved the settlement of US $ 248 million towards Direct Purchaser group and Retailer Opt-Out group subject to court approval
Subscribe To Our Newsletter & Stay Updated
